Parties Dispute Validity Of Sloan-Kettering Immunotherapy Patent

Mealey's (January 4, 2018, 3:27 PM EST) -- WASHINGTON, D.C. — In a Dec. 15 response brief, a patent challenger tells the Federal Circuit U.S. Court of Appeals that the Patent Trial and Appeal Board erred in finding no...
To view the full article, register now.